Results 41 to 50 of about 13,736 (182)

Evaluation of the diagnostic performance of colposcopy in the diagnosis of histologic cervical intraepithelial neoplasia 2+ (CIN2+)

open access: yesBMC Cancer, 2022
Background Colposcopy is a tool for triaging screen positive women regardless of method used for cervical cancer screening. The objective of this study was to evaluate the diagnostic performance of colposcopy in the diagnosis of histologic cervical ...
Namkha Dorji   +8 more
doaj   +1 more source

Occupational HPV Exposure in Otolaryngology: A Scoping Review of Detection, Risk, and Prevention

open access: yesThe Laryngoscope, EarlyView.
This scoping review identified 10 studies evaluating occupational HPV exposure in otolaryngology. HPV DNA was detected in surgical plume following some HPV‐related procedures, including up to 56.7% of CO2 laser plume samples, while the only study assessing oral HPV among exposed clinicians reported a prevalence of 2.2%, not exceeding that of the ...
Ying Jie Li   +2 more
wiley   +1 more source

Prevalence of human papillomavirus (HPV) and HPV-16 genotyping by real-time PCR in patients with several cervical pathologies

open access: yesBrazilian Journal of Infectious Diseases
PURPOSE: this study was planned to evaluate the prevalence of HPV (excepting type 16) and HPV 16 by real-time PCR in colposcopy patients and to interprete the results with age, age of first sexual intercourse (FSI), parity and Pap smear results. METHODS:
Bedia Dinc   +6 more
doaj   +1 more source

DNA‐Methylation for Risk‐Stratification of Women Without a Fully Visible Transformation Zone at Colposcopy: A Cross‐Sectional Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To evaluate the performance of DNA methylation markers for the detection of cervical precancer among screening‐positive older women without a fully visible transformation zone at colposcopy (TZ3). Design Cross‐sectional study. Setting Colposcopy clinics, Central Denmark Region, 2019–2021.
Karen Omann Binderup   +10 more
wiley   +1 more source

Bridging the Gap in Cervical Cancer Triage: Experience from Field-based Colposcopy Services in Rural India

open access: yesJournal of Integrated Health Sciences
Problem: Across the globe, cervical cancer is the second most common cancer among females. As per the World Health Organization, almost 90% of cervical cancer occurs in low- to middle-income countries.
Anand G. Shah, Mohit Nareshbhai Makwana
doaj   +1 more source

Adverse outcomes after colposcopy

open access: yesBMC Women's Health, 2011
Background Colposcopy is an essential part of the National Health Service Cervical Screening Programme (NHSCSP). It is used for both diagnosis and treatment of pre-cancerous cells of the cervix.
Damery Sarah L   +4 more
doaj   +1 more source

Utility of colposcopy for the screening and management of cervical cancer in Africa: a cross-sectional analysis of providers’ training and practices

open access: yesBMC Health Services Research
Introduction Cervical cancer is a public health issue in Africa with devastating socioeconomic consequences due to the lack of organized screening programs.
Joël Fokom Domgue   +20 more
doaj   +1 more source

Silicon dioxide vaginal gel and short‐term high‐risk human papillomavirus DNA detectability: A randomized controlled trial

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
In an independent randomized trial of 242 women with PCR‐confirmed hrHPV infection, 3 months of silicon dioxide‐based vaginal gel did not improve hrHPV DNA non‐detectability compared with observation alone (18% vs. 21%). Patient‐reported adverse events were more frequent with gel (32% vs. 2%), and overall patient satisfaction was lower.
Julia M. Hecken   +4 more
wiley   +1 more source

Colposcopy in pregnancy

open access: yesGinekologia Polska
Colposcopy is a method of enhanced diagnostics of cervical dysplasia, aimed at preventing cervical cancer. Its role is the same in and out of pregnancy. It is often performed after obtaining abnormal results of cervical cytology or a test for human papillomavirus (HPV16 and HPV18), or any other abnormal findings such as polyps, or unexplained bleeding ...
Edyta, Keczkowska   +5 more
openaire   +2 more sources

Clinical Validation of Four Point‐of‐Care High‐Risk HPV Assays, Including Two Reduced‐Valency Assays, for Cervical Cancer Screening in Low‐Resource Settings

open access: yesInternational Journal of Cancer, Volume 159, Issue 8, Page 2004-2014, 15 October 2026.
High‐risk human papillomavirus (hrHPV) testing improves cervical cancer screening by facilitating earlier detection and prevention. In low‐resource settings, however, cost and increased referrals limit its use. At the same time, many new and more affordable assays lack validation.
Neerja Bhatla   +28 more
wiley   +1 more source

Home - About - Disclaimer - Privacy